Cargando…

Identification of cutaneous immune-related adverse events by International Classification of Diseases codes and medication administration

Detalles Bibliográficos
Autores principales:	Chen, Wenxin, Wan, Guihong, Nguyen, Nga, Leung, Bonnie, Wen, Jun, Collier, Michael R., Kwatra, Shawn G., Semenov, Yevgeniy R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563326/ https://www.ncbi.nlm.nih.gov/pubmed/36248205 http://dx.doi.org/10.1016/j.jdin.2022.08.001

Ejemplares similares

The impact of stage-related features in melanoma recurrence prediction: A machine learning approach
por: Wan, Guihong, et al.
Publicado: (2022)

Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA
por: Kalinich, Mark, et al.
Publicado: (2021)

Prevalence of inverse psoriasis subtype with immune checkpoint inhibitors
por: Jfri, Abdulhadi, et al.
Publicado: (2022)

Prevention of adverse events in the administration of drugs
por: Diano, G, et al.
Publicado: (2010)

Demographics, Cutaneous Manifestations, and Comorbidities Associated with Progressive Cutaneous Sarcoidosis: A Retrospective Cohort Study
por: Lai, Jonathan, et al.
Publicado: (2023)

Proteomic and Phosphoproteomic Analysis Reveals that Neurokinin-1 Receptor (NK1R) Blockade with Aprepitant in Human Keratinocytes Activates a Distinct Subdomain of EGFR Signaling: Implications for the Anti-Pruritic Activity of NK1R Antagonists
por: Kwatra, Shawn G., et al.
Publicado: (2019)

Classification of non-coding variants with high pathogenic impact
por: Moyon, Lambert, et al.
Publicado: (2022)

ICD-10 codes used to identify adverse drug events in administrative data: a systematic review
por: Hohl, Corinne M, et al.
Publicado: (2014)

Association between Itch and Cancer in 3836 Pediatric Pruritus Patients at a Tertiary Care Center
por: Belzberg, Micah, et al.
Publicado: (2019)

Vemurafenib and cutaneous adverse events - report of five cases
por: Silva, Giselle de Barros, et al.
Publicado: (2015)

Management of immune-related cutaneous adverse events with dupilumab
por: Kuo, Alyce Mei-Shiuan, et al.
Publicado: (2023)

Cutaneous Adverse Events After COVID-19 Vaccination
por: Weschawalit, Sinee, et al.
Publicado: (2023)

271 Evaluation of Adverse Events Associated to Administration of Omalizumab
por: Gomez, R. Maximiliano, et al.
Publicado: (2012)

Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
por: Kato, Yamato, et al.
Publicado: (2015)

Risk of COVID‐19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors
por: Klebanov, Nikolai, et al.
Publicado: (2021)

Prediction of early-stage melanoma recurrence using clinical and histopathologic features
por: Wan, Guihong, et al.
Publicado: (2022)

Measuring adverse events following hip arthroplasty surgery using administrative data without relying on ICD-codes
por: Magnéli, Martin, et al.
Publicado: (2020)

An Observational Study on the Molecular Profiling of Primary Melanomas Reveals a Progression Dependence on Mitochondrial Activation
por: Gil, Jeovanis, et al.
Publicado: (2021)

Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy
por: Exley, Christopher
Publicado: (2014)

An unusual adverse event of azathioprine: Cutaneous small vessel vasculitis
por: Hanai, Shunichiro, et al.
Publicado: (2021)

Comorbidities Associated with Granuloma Annulare: A Cross-Sectional, Case-Control Study
por: Almazan, Erik, et al.
Publicado: (2020)

Detecting Adverse Drug Events with Rapidly Trained Classification Models
por: Chapman, Alec B., et al.
Publicado: (2019)

Neurological adverse events following regional anesthesia administration
por: Kent, Christopher D, et al.
Publicado: (2010)

Reporting adverse drug events to the Therapeutic Goods Administration
por: Martin, Jennifer H, et al.
Publicado: (2021)

Somatic mutations reveal hyperactive Notch signaling and racial disparities in prurigo nodularis
por: Rajeh, Ahmad, et al.
Publicado: (2023)

A systematic review of adverse drug events associated with administration of common asthma medications in children
por: Leung, James S., et al.
Publicado: (2017)

Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis
por: Kolb-Mäurer, Annette, et al.
Publicado: (2015)

The Clinical and Histopathological Features of Cutaneous Immune-Related Adverse Events and Their Outcomes
por: Hashimoto, Hiroki, et al.
Publicado: (2021)

Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Literature Review
por: Apalla, Zoe, et al.
Publicado: (2021)

Identifying Adverse Events Using International Classification of Diseases, Tenth Revision Y Codes in Korea: A Cross-sectional Study
por: Ock, Minsu, et al.
Publicado: (2018)

Pharmacological inhibition of lipolysis prevents adverse metabolic outcomes during glucocorticoid administration
por: Linden, Melissa A., et al.
Publicado: (2023)

Cutaneous Toxicity Associated With Enfortumab Vedotin: A Real-Word Study Leveraging U.S. Food and Drug Administration Adverse Event Reporting System
por: Yang, Hui, et al.
Publicado: (2022)

Automatically Recognizing Medication and Adverse Event Information From Food and Drug Administration’s Adverse Event Reporting System Narratives
por: Polepalli Ramesh, Balaji, et al.
Publicado: (2014)

META-INSTI: metabolic adverse events following integrase strand transfer inhibitor administration in spontaneous adverse event reports
por: Murray, Milena M, et al.
Publicado: (2023)

Cutaneous adverse events associated with long-term immunomodulating therapy in multiple sclerosis
por: Balak, Deepak MW, et al.
Publicado: (2011)

The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
por: Owczarek, Witold, et al.
Publicado: (2017)

Cutaneous Adverse Events Associated with Immune Checkpoint Inhibitors: A Review Article
por: Chen, Chieh-Hsun, et al.
Publicado: (2022)

In Silico Approach to Predict Severe Cutaneous Adverse Reactions Using the Japanese Adverse Drug Event Report Database
por: Ambe, Kaori, et al.
Publicado: (2021)

Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
por: Toki, Tadashi, et al.
Publicado: (2018)

Adverse Events Associated With the Use of Sipuleucel-T Reported to the US Food and Drug Administration’s Adverse Event Reporting System, 2010-2017
por: Dores, Graça M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5mti6s51d1mckmavsc9ab4828l